Primary outcome measure
The primary clinical outcome was the difference in ICP between exenatide and placebo, as measured by telemetric ICP monitoring at 2.5 h, 24 h and 12 weeks. The difference in ICP between arms at 2.5 h was −4.2 (2.1) [mean (SD) mmHg], 
Primary outcome measures